| Biocon Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532523 |
NSE Symbol : BIOCON |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE376G01013 |
Div & Yield% : 0.11 |
EPS(TTM) : 0.60 |
|
Book Value(₹) : 119.54 |
Market Cap(₹Cr) : 52,515.93 |
Face Value(₹) : 5.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,242.60 | 2,127.30 | 1,992.90 | 1,738.20 | 2,028.40 |
| Other Income | 849.80 | 207.50 | 3,134.20 | 187.20 | 150.20 |
| Stock Adjustments | 54.60 | 99.10 | -3.20 | 105.80 | -36.70 |
| Total Income | 3,147.00 | 2,433.90 | 5,123.90 | 2,031.20 | 2,141.90 |
| EXPENDITURE : | |||||
| Raw Materials | 1,085.40 | 1,033.80 | 981.00 | 914.00 | 761.60 |
| Power and Fuel Cost | 192.00 | 215.30 | 279.20 | 231.00 | 186.00 |
| Other Manufacturing Expenses | 163.80 | 155.40 | 127.10 | 130.50 | 147.00 |
| Selling and Administration Expenses | 172.00 | 135.00 | 112.20 | 106.70 | 128.40 |
| Miscellaneous Expenses | 6.90 | -28.10 | 32.90 | 33.00 | 66.00 |
| Employee Benefit Expenses | 501.30 | 452.30 | 433.80 | 367.70 | 390.20 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 1,025.60 | 470.20 | 3,157.70 | 248.30 | 462.70 |
| Interest | 236.90 | 198.80 | 69.60 | 0.40 | 0.40 |
| Gross Profit | 788.70 | 271.40 | 3,088.10 | 247.90 | 462.30 |
| Depreciation | 127.80 | 121.10 | 116.90 | 108.20 | 103.50 |
| Profit Before Tax | 660.90 | 150.30 | 2,971.20 | 139.70 | 358.80 |
| Current Tax | 30.60 | 15.10 | 132.70 | 60.70 | 73.50 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 21.00 | 15.90 | -9.90 | -7.10 | 4.80 |
| Reported Net Profit | 609.30 | 119.30 | 2,848.40 | 86.10 | 280.50 |
| Extraordinary Items | 564.49 | 13.41 | 2,861.73 | 2.92 | 3.00 |
| Adjusted Net Profit | 44.81 | 105.89 | -13.33 | 83.18 | 277.50 |
| Adjustment below Net Profit | -1.30 | 30.70 | 29.40 | -59.40 | 30.40 |
| Profit/Loss Balance carried down | 9,920.50 | 9,950.60 | 7,132.80 | 7,106.10 | 6,795.20 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 60.00 | 180.10 | 60.00 | 0.00 | 0.00 |
| P & L Balance carried down | 10,468.50 | 9,920.50 | 9,950.60 | 7,132.80 | 7,106.10 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 10.00 | 10.00 | 30.00 | 10.00 | 0.00 |
| Dividend Per Share(Rs) | 0.50 | 0.50 | 1.50 | 0.50 | 0.00 |
| Earnings Per Share-Unit Curr | 5.07 | 0.99 | 23.72 | 0.72 | 2.34 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 95.98 | 90.88 | 90.91 | 67.40 | 65.88 |
| Book Value(Adj)-Unit Curr | 95.98 | 90.88 | 90.91 | 67.40 | 65.88 |